Patient eligibility
The Pharmaceutical Benefits Scheme (PBS) subsidises treatment with riociguat under the National Health Act 1953, section 100 for patients aged 18 years or over with CTEPH.
Patients must be eligible for the PBS and meet the relevant restriction criteria.
The Schedule of Pharmaceutical Benefits on the PBS website outlines the restrictions for prescribing riociguat.
Section 100 arrangements
riociguat
This item is only PBS-subsidised for non-admitted patients, day admitted patients, or patients on discharge who are attending:
- an approved private hospital
- a public hospital.
This item isn’t PBS-subsidised for public hospital in-patients. You must include the hospital name and provider number on the authority application form.
Authority applications
All patients applying for riociguat treatment must be treated in a centre with expertise in the management of CTEPH.
Applying for initial treatment
Apply for initial authority approval to prescribe PBS-subsidised riociguat to treat CTEPH in writing and either:
- use HPOS Form upload
- mail to PBS Complex Drugs Programs.
All written applications must include the completed:
- authority prescription form or forms
- Chronic thromboembolic pulmonary hypertension - riociguat - initial authority application form
- relevant attachments.
Applying for continuing treatment
Apply for continuing authority approval to prescribe PBS-subsidised riociguat to treat CTEPH in writing and either:
- use HPOS Form upload
- mail to PBS Complex Drugs Programs.
All written applications must include the completed:
- authority prescription form or forms
- Chronic thromboembolic pulmonary hypertension - riociguat - continuing authority application form
- relevant attachments.
More information
Call the PBS Complex Drugs Programs enquiry line for more information.